Differential susceptibility to chemically induced thymic lymphomas in SENCARB and SSIN inbred mice. 2006

Fernando Benavides, and Gregorio Gomez, and Ann Venables-Griffith, and Isabel Lambertz, and Mónica Flores, and Joe M Angel, and Robin Fuchs-Young, and Ellen R Richie, and Claudio J Conti
Science-Park Research Division, The University of Texas M. D. Anderson Cancer Center, Smithville, 78957, USA.

In the past 20 yr, several inbred strains have been derived from SENCAR outbred mice. These strains display different susceptibility to the induction of papillomas and progression to squamous cell carcinomas (SCC) in the skin after chemical carcinogenesis. In the present study, we showed that one of these strains SENCARB/Pt was highly susceptible to the development of N-methyl-N-nitrosourea (MNU)- and 7,12-dimethylbenz[a]anthracene (DMBA)-induced lymphomas. In contrast, the SSIN/Sprd inbred strain is completely resistant to T-cell lymphomagenesis by both carcinogens. Within 175 d after a single injection of 75 mg/kilogram body weight (kbw) of MNU, SENCARB/Pt mice exhibited a 91.6% incidence of lymphoma. In addition, during an independent tumorigenesis study with repeated doses of intragastric DMBA, SENCARB/Pt mice showed an incidence of 75% lymphoma development 300 d after the last treatment. Histopathological and flow cytometric parameters indicated that the lymphomas were of the T-cell lineage. In order to study the genetics of MNU-induced tumorigenesis, we generated F1 hybrid mice between SSIN/Sprd and SENCARB/Pt mice. Tumor incidence in MNU-injected F1 mice suggested that the high tumor incidence is a dominant trait. Loss of heterozygosity (LOH) analysis in these tumor samples revealed allelic imbalances on chromosomes 15 and 19. Given that these inbred strains are closely related, it is likely that a relatively small number of loci are responsible for the observed differences in susceptibility. Therefore, these SENCAR inbred strains constitute important new tools to study the genetic basis of resistance and susceptibility to chemically induced thymic lymphoma formation.

UI MeSH Term Description Entries
D008223 Lymphoma A general term for various neoplastic diseases of the lymphoid tissue. Germinoblastoma,Lymphoma, Malignant,Reticulolymphosarcoma,Sarcoma, Germinoblastic,Germinoblastic Sarcoma,Germinoblastic Sarcomas,Germinoblastomas,Lymphomas,Lymphomas, Malignant,Malignant Lymphoma,Malignant Lymphomas,Reticulolymphosarcomas,Sarcomas, Germinoblastic
D008770 Methylnitrosourea A nitrosourea compound with alkylating, carcinogenic, and mutagenic properties. Nitrosomethylurea,N-Methyl-N-nitrosourea,NSC-23909,N Methyl N nitrosourea,NSC 23909,NSC23909
D008806 Mice, Inbred AKR An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. Mice, AKR,Mouse, AKR,Mouse, Inbred AKR,AKR Mice,AKR Mice, Inbred,AKR Mouse,AKR Mouse, Inbred,Inbred AKR Mice,Inbred AKR Mouse
D008815 Mice, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations, or by parent x offspring matings carried out with certain restrictions. All animals within an inbred strain trace back to a common ancestor in the twentieth generation. Inbred Mouse Strains,Inbred Strain of Mice,Inbred Strain of Mouse,Inbred Strains of Mice,Mouse, Inbred Strain,Inbred Mouse Strain,Mouse Inbred Strain,Mouse Inbred Strains,Mouse Strain, Inbred,Mouse Strains, Inbred,Strain, Inbred Mouse,Strains, Inbred Mouse
D002273 Carcinogens Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. Carcinogen,Oncogen,Oncogens,Tumor Initiator,Tumor Initiators,Tumor Promoter,Tumor Promoters,Initiator, Tumor,Initiators, Tumor,Promoter, Tumor,Promoters, Tumor
D005260 Female Females
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013045 Species Specificity The restriction of a characteristic behavior, anatomical structure or physical system, such as immune response; metabolic response, or gene or gene variant to the members of one species. It refers to that property which differentiates one species from another but it is also used for phylogenetic levels higher or lower than the species. Species Specificities,Specificities, Species,Specificity, Species
D013953 Thymus Neoplasms Tumors or cancer of the THYMUS GLAND. Cancer of Thymus,Thymus Cancer,Thymus Tumors,Cancer of the Thymus,Neoplasms, Thymic,Neoplasms, Thymus,Thymic Cancer,Thymic Neoplasms,Thymic Tumors,Cancer, Thymic,Cancer, Thymus,Cancers, Thymic,Cancers, Thymus,Neoplasm, Thymic,Neoplasm, Thymus,Thymic Cancers,Thymic Neoplasm,Thymic Tumor,Thymus Cancers,Thymus Neoplasm,Thymus Tumor,Tumor, Thymic,Tumor, Thymus,Tumors, Thymic,Tumors, Thymus

Related Publications

Fernando Benavides, and Gregorio Gomez, and Ann Venables-Griffith, and Isabel Lambertz, and Mónica Flores, and Joe M Angel, and Robin Fuchs-Young, and Ellen R Richie, and Claudio J Conti
June 1972, Journal of the National Cancer Institute,
Fernando Benavides, and Gregorio Gomez, and Ann Venables-Griffith, and Isabel Lambertz, and Mónica Flores, and Joe M Angel, and Robin Fuchs-Young, and Ellen R Richie, and Claudio J Conti
January 1995, Experimental lung research,
Fernando Benavides, and Gregorio Gomez, and Ann Venables-Griffith, and Isabel Lambertz, and Mónica Flores, and Joe M Angel, and Robin Fuchs-Young, and Ellen R Richie, and Claudio J Conti
October 1991, Cancer research,
Fernando Benavides, and Gregorio Gomez, and Ann Venables-Griffith, and Isabel Lambertz, and Mónica Flores, and Joe M Angel, and Robin Fuchs-Young, and Ellen R Richie, and Claudio J Conti
January 1985, Proceedings of the National Academy of Sciences of the United States of America,
Fernando Benavides, and Gregorio Gomez, and Ann Venables-Griffith, and Isabel Lambertz, and Mónica Flores, and Joe M Angel, and Robin Fuchs-Young, and Ellen R Richie, and Claudio J Conti
September 1995, Cancer research,
Fernando Benavides, and Gregorio Gomez, and Ann Venables-Griffith, and Isabel Lambertz, and Mónica Flores, and Joe M Angel, and Robin Fuchs-Young, and Ellen R Richie, and Claudio J Conti
January 1983, Haematology and blood transfusion,
Fernando Benavides, and Gregorio Gomez, and Ann Venables-Griffith, and Isabel Lambertz, and Mónica Flores, and Joe M Angel, and Robin Fuchs-Young, and Ellen R Richie, and Claudio J Conti
April 1985, Cancer research,
Fernando Benavides, and Gregorio Gomez, and Ann Venables-Griffith, and Isabel Lambertz, and Mónica Flores, and Joe M Angel, and Robin Fuchs-Young, and Ellen R Richie, and Claudio J Conti
April 1993, Journal of virology,
Fernando Benavides, and Gregorio Gomez, and Ann Venables-Griffith, and Isabel Lambertz, and Mónica Flores, and Joe M Angel, and Robin Fuchs-Young, and Ellen R Richie, and Claudio J Conti
January 2013, American journal of physiology. Lung cellular and molecular physiology,
Fernando Benavides, and Gregorio Gomez, and Ann Venables-Griffith, and Isabel Lambertz, and Mónica Flores, and Joe M Angel, and Robin Fuchs-Young, and Ellen R Richie, and Claudio J Conti
June 2002, Carcinogenesis,
Copied contents to your clipboard!